The stock had underperformed the market over the past one month till Oct. 12, 2010, falling 6.21% compared with the Sensex`s 7.47% rise. It outperformed the market in past one quarter, gaining 46.57% as against 12.63% rise in the Sensex.
Total volume of shares traded on the bourses today was lower by 93.75% to 15,896 compared with 22-day average volume of 254,173. Recently the company announced rise of 74.63% in standalone net profit on y-o-y basis to Rs 233.46 million, while total income rose 73.17% y-o-y basis to Rs 3.60 billion for the quarter ended June 2010.
On August 16, 2010, the board of directors approved final dividend of 15% or Rs 1.5 a share. The company has an equity capital of Rs 14.47 million. Face value of share is at Rs 10. The company has market capitalization of Rs 3.91 billion as on Oct. 12, 2010.
Shares of Surya Pharmaceutical gained Rs 3.65, or 1.35%, to trade at Rs 274.15. The total volume of shares traded was 5,768 at the BSE (9.53 a.m., Wednesday).
No comments:
Post a Comment